Cargando…

Affordability of medicines in the European Union

BACKGROUND: Medications and their prices are key issues for healthcare. Although access to medicines at affordable prices had been specified as a key objective of the European Health Policy, it seems that these goals have not been achieved. Therefore, we attempted an evaluation of affordability of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaprutko, Tomasz, Kopciuch, Dorota, Kus, Krzysztof, Merks, Piotr, Nowicka, Monika, Augustyniak, Izabela, Nowakowska, Elżbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328386/ https://www.ncbi.nlm.nih.gov/pubmed/28241019 http://dx.doi.org/10.1371/journal.pone.0172753

Ejemplares similares

A survey of pharmacists' knowledge, attitudes and barriers in pharmaceutical care concept in Poland
por: Kopciuch, Dorota, et al.
Publicado: (2021)

Effect of Different Blood-Pressure-Lowering Regimens on the Blood Pressure Control among Hypertensive Patients Treated in Hospital Conditions
por: Paczkowska, Anna, et al.
Publicado: (2020)

Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018
por: Zaprutko, Tomasz, et al.
Publicado: (2021)

Impact of patient knowledge on hypertension treatment adherence and efficacy: A single-centre study in Poland
por: Paczkowska, Anna, et al.
Publicado: (2021)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
por: Paczkowska, Anna, et al.
Publicado: (2021)

Pharmacovigilance practice among pediatric neurologists from Poland and Germany
por: Kopciuch, Dorota, et al.
Publicado: (2023)

Pharmacovigilance in Pediatric Patients with Epilepsy Using Antiepileptic Drugs
por: Kopciuch, Dorota, et al.
Publicado: (2022)

Pharmacoeconomics Aspects of Antiepileptic Drugs in Pediatric Patients with Epilepsy
por: Kopciuch, Dorota, et al.
Publicado: (2022)

Assessment of the Impact of the COVID-19 Pandemic on the Pro-Health Behavior of Poles
por: Hoffmann, Karolina, et al.
Publicado: (2022)

The Mental Health of Poles during the COVID-19 Pandemic
por: Hoffmann, Karolina, et al.
Publicado: (2023)

Safety Profile of COVID-19 Vaccines among Healthcare Workers in Poland
por: Paczkowska, Anna, et al.
Publicado: (2022)

The Growing Market for Natural Cosmetics in Poland: Consumer Preferences and Industry Trends
por: Ratajczak, Piotr, et al.
Publicado: (2023)

Assessment of Patients’ Quality of Life during Conservative Treatment after Distal Radius Fracture
por: Ratajczak, Piotr, et al.
Publicado: (2022)

Neurologists’ Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients—Comparative Analysis from Poland and Egypt
por: Kopciuch, Dorota, et al.
Publicado: (2022)

Association between Compliance with COVID-19 Restrictions and the Risk of SARS-CoV-2 Infection in Poland
por: Hoffmann, Karolina, et al.
Publicado: (2023)

Facebook as a source of access to medicines
por: Zaprutko, Tomasz, et al.
Publicado: (2022)

The Impact of Health Policy on Patients’ Awareness of the Risks Associated with Obesity: An International Multicenter Study in Poland and Germany
por: Paczkowska, Anna, et al.
Publicado: (2022)

Impact of bariatric surgery on depression, anxiety and stress symptoms among patients with morbid obesity: international multicentre study in Poland and Germany
por: Paczkowska, Anna, et al.
Publicado: (2022)

Adherence of Obese Patients from Poland and Germany and Its Impact on the Effectiveness of Morbid Obesity Treatment
por: Hoffmann, Karolina, et al.
Publicado: (2022)

Tozinameran (Pfizer, BioNTech) and Elasomeran (Moderna) Efficacy in COVID-19—A Systematic Review of Randomised Controlled Trial Studies
por: Ratajczak, Piotr, et al.
Publicado: (2023)

The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016
por: Zaprutko, Tomasz, et al.
Publicado: (2018)

The comparison of Kardia Mobile and Hartmann Veroval 2 in 1 in detecting first diagnosed atrial fibrillation
por: Zaprutko, Tomasz, et al.
Publicado: (2023)

The Cost of Inpatient Care of Schizophrenia in the Polish and Ukrainian Academic Centers—Poznan and Lviv
por: Zaprutko, Tomasz, et al.
Publicado: (2014)

The Cost of Inpatient Care of Schizophrenia and Treatment Schedules Used in German Academic Center: Kiel
por: Zaprutko, Tomasz, et al.
Publicado: (2015)

Correction: The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016
por: Zaprutko, Tomasz, et al.
Publicado: (2018)

Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine
por: Zaprutko, Tomasz, et al.
Publicado: (2022)

The union advantage: union membership, access to care, and the Affordable Care Act
por: Petach, Luke, et al.
Publicado: (2022)

European Union ban on Ayurvedic Medicines
por: Patwardhan, Bhushan
Publicado: (2011)

An overview of Personalized Medicine landscape and policies in the European Union
por: Beccia, F, et al.
Publicado: (2022)

Scrutinizing Pork Price Volatility in the European Union over the Last Decade
por: Utnik-Banaś, Katarzyna, et al.
Publicado: (2022)

Use of biomarkers in the context of orphan medicines designation in the European Union
por: Tsigkos, Stelios, et al.
Publicado: (2014)

Valorising and Creating Access to Innovative Medicines in the European Union
por: Annemans, Lieven, et al.
Publicado: (2011)

A Measure to Target Antipoverty Policies in the European Union Regions
por: Annoni, Paola, et al.
Publicado: (2014)

The European Health Union and the protection of public health in the European Union: Is the European Union prepared for future cross-border health threats?
por: Seitz, Claudia
Publicado: (2023)

A survey of experts on personalized medicine landscape in European Union and China
por: Hoxhaj, Ilda, et al.
Publicado: (2023)

Promoting convergence and closing gaps using affordability-based minimum taxes: an illustration using the European Union Tobacco Tax Directive
por: Branston, J Robert, et al.
Publicado: (2023)

EMEA and Gene Therapy Medicinal Products Development in the European Union
por: Papaluca Amati, Marisa, et al.
Publicado: (2003)

Improving the Safety of Medicines in the European Union: From Signals to Action
por: Potts, Joanne, et al.
Publicado: (2019)

The challenges of access to innovative medicines with limited evidence in the European Union
por: Vallano, Antonio, et al.
Publicado: (2023)

Awareness of the implementation of the Falsified Medicines Directive among pharmaceutical companies’ professionals in the European Economic Area
por: WŁodarczak, Urszula, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ql4bof03t87isms0eeg0rptvf5